MedTrace Logo

Effect of an Artificial Pancreas in Patients Undergoing Hepatic Resection

NCT00659698 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2008-04-16

No results posted yet for this study

Summary

This study evaluated that strict control of perioperative blood glucose following hepatic resection by using an artificial pancreas would improve postoperative surgical site infection.

Conditions

Interventions

DEVICE

the closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan)

artificial pancreas

Sponsors & Collaborators

  • Kochi University

    lead OTHER

Principal Investigators

  • Takehiro Okabayashi, MD · Kochi Medical School

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00659698 on ClinicalTrials.gov